General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-03 | 2023-12 | -0.57 | N/A | N/A | N/A |
2023-11-07 | 2023-09 | -0.69 | -0.66 | 0.03 | 4.35% |
2023-08-08 | 2023-06 | -0.72 | -0.67 | 0.05 | 6.94% |
2023-05-09 | 2023-03 | -0.54 | 0.21 | 0.75 | 138.89% |
2023-03-29 | 2022-12 | -0.45 | 0.38 | 0.83 | 184.44% |
2022-11-07 | 2022-09 | -1.28 | -0.92 | 0.36 | 28.13% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Cantor Fitzgerald | Upgrade | Neutral | |
2023-09-05 | HSBC | Upgrade | Buy | |
2023-07-18 | B of A Securities | Upgrade | Neutral | Buy |
2023-07-10 | Morgan Stanley | Upgrade | Underweight | Underweight |
2023-05-31 | Barclays | Upgrade | Equal-Weight | Overweight |
2023-04-27 | JP Morgan | Upgrade | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-06-15 | AGWUNOBI JOHN O | Director | 26.46K | Stock Award(Grant) |
2024-02-29 | COLVIN RICHARD A | Officer | 118.37K | Sale |
2024-03-03 | KLIMA THOMAS J | Chief Operating Officer | 124.84K | Sale |
2023-12-05 | KRAWTSCHUK CHRISTOPHER CPA | Chief Financial Officer | 45.47K | Sale |
2023-06-15 | LEIDERMAN ELISABETH M.D. | Director | 22.26K | Stock Award(Grant) |
2023-06-15 | LESCHLY NICK | Director | 459.64K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 16.36M | 53.82M | 15.29% |
2023-06-29 | Blackrock Inc. | 8.79M | 28.93M | 8.22% |
2023-06-29 | Tang Capital Management, LLC | 7.38M | 24.29M | 6.90% |
2023-06-29 | Pfm Health Sciences, Lp | 7.29M | 23.97M | 6.81% |
2023-06-29 | Vanguard Group Inc | 5.57M | 18.33M | 5.21% |
2023-06-29 | Granahan Investment Management LLC | 4.86M | 15.98M | 4.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 13.88M | 52.34M | 12.98% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.39M | 11.15M | 3.17% |
2023-08-30 | iShares Russell 2000 ETF | 2.48M | 9.36M | 2.32% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.48M | 4.86M | 1.38% |
2023-09-29 | Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 1.32M | 4.00M | 1.23% |
2023-08-30 | iShares Russell 2000 Value ETF | 987.26K | 3.72M | 0.92% |
Split | Date |
---|---|
1544 : 1000 | 2021-11-05 |
You know as I do the valuation is ridiculous and at 193 market cap absurd by any measure
This stock could easily drop to .50 until the momentum changes. You can forget the market cap because until you have a genuine turn around in biotech or more buyers than sellers it’s a red headed stepchild
It will take at least a year to hit $3
By waiting to long management will destroy the value of the company in a buyout. The management should be aggressively searching for a buyer
It’s not a retail game anymore it’s indexed and ETF that call the shots. I think an acquisition is the only hope but it has to happen very soon or we did on the vine. The rules have changed forever and the biotech glory runs are kaput.
The horrible management of this company sealed its fate, they were research driven but not good financial leadership
Institutional investors are just tossing dice on this and don’t care win or lose, it’s like buying a 100-1 horse with pocket money. These guys spend twice that amount on their Xmas parties. You can’t take it seriously
I have a reality check, you explain to me how the true value of BLUE is 175 mill cap? I get that Wall Street could drive it down to 0 but I’m talking about the enterprise valuation. What am I missing here? The court case will be settled for a few $ because the plaintiff can’t possibly do anything with a victory
Our CEO is Nero and fiddles as we burn
Imagine in the $100’s🤪
I have to admit I’m already crazy to have bought it. I can’t even look in the mirror and that was at 2.40
The GOO did think funding for SCD was to woke and banned it in Fla.
There’s no way of knowin, which direction we are goin!
The fucking management doesn’t care because they have no skin in the game on ownership
Or reverse 1 for 10
They should do stock buyback.
It’s a fucking death rattle
It needs a restructuring now to stop the cash hemorrhage